Jump to content

Catherine Stedman

Add links
From Wikipedia, the free encyclopedia

Catherine Stedman
ChildrenWilliam Stedman
Academic background
Alma materUniversity of Sydney
Thesis
  • Role of nuclear receptors in bile acid disposition and detoxification (2006)
Academic work
Discipline
  • Pharmacology
  • gastroenterology
InstitutionsUniversity of Otago
WebsiteUniversity of Otago profile

Catherine Ann Malcolm Stedman is a New Zealand pharmacologist and gastroenterologist, and is a clinical professor at the University of Otago, specialising in hepatitis C drug development. She is the first woman gastroenterologist to become a professor of medicine in New Zealand.

Academic career

[edit]

Stedman completed her undergraduate medical degree at the University of Otago, and then undertook a PhD titled Role of nuclear receptors in bile acid disposition and detoxification at the University of Sydney in 2006.[1] Her clinical training in pharmacology and gastroenterology took place at Christchurch Hospital and Westmead Hospital in Sydney.[2] Stedman then worked in the Salk Institute, and on drug safety for a pharmaceutical company.[2] Stedman returned to Christchurch Hospital as a consultant gastroenterologist and joined the faculty of the University of Otago, rising to clinical associate professor in 2015 and full professor in 2023.[3][4] She is the first woman gastroenterologist to become a professor of medicine in New Zealand.[2]

Stedman's research focuses on drug development for hepatitis C treatment, although she is also interested in autoimmune liver diseases, and how they affect the lives and life expectancy of people who have them. Stedman has been a principal investigator in a large number of clinical trials aimed at testing antiviral therapies, and led the first successful clinical trial in the world to show that oral antiviral treatment could cure hepatitis C.[4] Stedman has also led trials for antiviral therapies aimed at patients with liver failure resulting from hepatitis C.[4] As a result of these trials, and other potential therapies, the World Health Organization has proposed elimination of hepatitis C.[4][5][6][7]

As of 2024, Stedman is the president of the New Zealand Society of Gastroenterology.[2]

Honours and awards

[edit]

In 2019 Stedman was awarded the Gold Research Medal by the University of Otago Christchurch campus.[8]

Selected works

[edit]
Scholia has a profile for Catherine Stedman (Q115736169).

References

[edit]
  1. ^ Stedman, Catherine Ann Malcolm (2006). Role of nuclear receptors in bile acid disposition and detoxification (PhD thesis). University of Sydney. OCLC 224978188.
  2. ^ a b c d "Executive Committee". New Zealand Society Of Gastroenterology. Retrieved 29 March 2024.
  3. ^ Otago, University of (29 January 2015). "Otago announces professorial promotions". www.otago.ac.nz. Retrieved 29 March 2024.
  4. ^ a b c d University of Otago, Wellington (16 December 2022). "Otago announces 39 new professors". www.otago.ac.nz. Retrieved 29 March 2024.
  5. ^ Otago, University of (2 August 2023). "Profile". www.otago.ac.nz. Retrieved 29 March 2024.
  6. ^ "Invited speakers". GASTRO. Retrieved 29 March 2024.
  7. ^ "Rotorua GP CME 2014 - Catherine Stedman". www.gpcme.co.nz. Retrieved 29 March 2024.
  8. ^ University of Otago, Christchurch (24 July 2019). "Chch campus recognises academic success and values". www.otago.ac.nz. Retrieved 29 March 2024.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Catherine_Stedman&oldid=1253473548"